ZENOTECH LABORATORIES
|
The Current P/E Ratio of ZENOTECH LABORATORIES is 69.56.
| Share Price | ₹37.7 | Apr 01,2026 |
| Market Cap | ₹230.0 Cr | |
| Earnings-TTM | ₹3.3 Cr | TTM-Standalone Results |
| Price/Earnings | 69.56x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ZENOTECH LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹230.0 Cr] as on Apr 01,2026
(/) Earnings [ ₹3.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 69.56x ]
Thus, for ZENOTECH LABORATORIES , the investors are currently willing to pay 69.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZENOTECH LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZENOTECH LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZENOTECH LABORATORIES
PE Ratio Performance Analysis for ZENOTECH LABORATORIES
- ZENOTECH LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 27.71x.
- ZENOTECH LABORATORIES 's operated at median p/e ratio of 24.79x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZENOTECH LABORATORIES 's p/e ratio peaked in Mar2025 at 56.45x.
- ZENOTECH LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does ZENOTECH LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ZENOTECH LABORATORIES | 3.31 | 69.56 | 230.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.70 | 414,713.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 63.26 | 156,811.0 |
| CIPLA LTD | 4,544.70 | 21.26 | 96,602.7 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 61.20 | 139,052.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.32 | 100,927.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.98 | 82,613.1 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.61 | 86,883.3 |
| LUPIN LTD | 4,669.18 | 22.26 | 103,944.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 22.19 | 77,949.4 |
| ABBOTT INDIA LTD | 1,524.13 | 36.93 | 56,293.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZENOTECH LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.61x |
| Max industry PE | 69.56x |
| Median industry PE | 36.93x |
| Average industry PE | 37.84x |
You may also like the below Video Courses